{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:10:22Z","timestamp":1783926622499,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.iac.2026.04.001","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:25:42Z","timestamp":1783639542000},"page":"533-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Special Considerations in Atopic Dermatitis in Young Children"],"prefix":"10.1016","volume":"46","author":[{"given":"Mudra","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette B.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iac.2026.04.001_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0190-9622(94)70004-4","article-title":"The prevalence of childhood atopic eczema in a general population","volume":"30","author":"Kay","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"S1","key":"10.1016\/j.iac.2026.04.001_bib2","first-page":"S47","article-title":"Risk Factors of Onset Time and Persistence of Atopic Dermatitis in Children Under Age 5 Years: A Cross-Sectional Study","volume":"35","author":"Song","year":"2024","journal-title":"Dermatitis"},{"issue":"6","key":"10.1016\/j.iac.2026.04.001_bib3","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3390\/jcm4061217","article-title":"The role of malassezia spp. in atopic dermatitis","volume":"4","author":"Glatz","year":"2015","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.iac.2026.04.001_bib4","first-page":"191","article-title":"Molluscum contagiosum virus infection can trigger atopic dermatitis disease onset or flare","volume":"102","author":"Silverberg","year":"2018","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.iac.2026.04.001_bib5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4103\/0019-5154.193677","article-title":"Topical therapy in atopic dermatitis in children","volume":"61","author":"Sathishkumar","year":"2016","journal-title":"Indian J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.001_bib6","doi-asserted-by":"crossref","first-page":"e1735","DOI":"10.1542\/peds.2014-2812","article-title":"Section on dermatology. atopic dermatitis: skin-directed management","volume":"134","author":"Tollefson","year":"2014","journal-title":"Pediatrics"},{"issue":"13","key":"10.1016\/j.iac.2026.04.001_bib7","first-page":"224","article-title":"Atopic dermatitis in children and adults\u2014diagnosis and treatment","volume":"120","author":"Wollenberg","year":"2023","journal-title":"Dtsch Arztebl Int"},{"issue":"suppl","key":"10.1016\/j.iac.2026.04.001_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereol (Stockh)"},{"issue":"10","key":"10.1016\/j.iac.2026.04.001_bib9","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1468-3083.2010.03953.x","article-title":"Clinical features of atopic dermatitis in a hospital-based setting in China","volume":"25","author":"Shi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.001_bib10","first-page":"419","article-title":"Minor criteria for atopic dermatitis in children","volume":"20","author":"Wahab","year":"2011","journal-title":"Mymensingh Med J"},{"issue":"1","key":"10.1016\/j.iac.2026.04.001_bib11","first-page":"32","article-title":"a cross-sectional study comparing application of Hanifin and Rajka Criteria in Indian Pediatric Atopic Dermatitis Patients to that of Other Countries","volume":"14","author":"Shetty","year":"2022","journal-title":"Indian Dermatol Online J"},{"issue":"5 Pt 1","key":"10.1016\/j.iac.2026.04.001_bib12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mjd.2000.110070","article-title":"Hanifin\u2019s and Rajka\u2019s minor criteria for atopic dermatitis: which do 2-year-olds exhibit?","volume":"43","author":"B\u00f6hme","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.iac.2026.04.001_bib13","first-page":"1496","article-title":"Diagnostic criteria for atopic dermatitis in Thai children","volume":"87","author":"Wisuthsarewong","year":"2004","journal-title":"J Med Assoc Thai"},{"issue":"5","key":"10.1016\/j.iac.2026.04.001_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archderm.142.5.561","article-title":"Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children","volume":"142","author":"Halkjaer","year":"2006","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.001_bib15","doi-asserted-by":"crossref","first-page":"e13614","DOI":"10.1111\/srt.13614","article-title":"Clinical features of atopic dermatitis in pediatric patients with skin of color and comparison with different phototypes","volume":"30","author":"Herzum","year":"2024","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.iac.2026.04.001_bib16","article-title":"Pediatric atopic dermatitis: assessment of burden based on lesional morphology","author":"Luu","year":"2022","journal-title":"PeDRA"},{"issue":"Suppl 2","key":"10.1016\/j.iac.2026.04.001_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/pde.14774","article-title":"Review article: Emerging issues in pediatric skin of color, Part 2","volume":"38","author":"Mitchell","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.001_bib18","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jaip.2017.10.005","article-title":"Phenotypical differences of childhood- and adult-onset atopic dermatitis","volume":"6","author":"Silverberg","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"Suppl 2","key":"10.1016\/j.iac.2026.04.001_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/pde.14755","article-title":"A systematic scoping review of racial, ethnic, and socioeconomic health disparities in pediatric dermatology","volume":"38","author":"Kuo","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"10.1016\/j.iac.2026.04.001_bib20","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/jdv.15972","article-title":"Position Statement on Atopic Dermatitis in Sub-Saharan Africa: current status and roadmap","volume":"33","author":"Schmid-Grendelmeier","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.iac.2026.04.001_bib21","unstructured":"Silverberg N.B., Erythema in Children of Color. AAD Skin of Color Curriculum. Available at: https:\/\/learning.aad.org\/Listing\/Skin-of-Color-Curriculum-5719. Accessed June 12, 2024."},{"issue":"4","key":"10.1016\/j.iac.2026.04.001_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.clindermatol.2017.03.007","article-title":"Typical and atypical clinical appearance of atopic dermatitis","volume":"35","author":"Silverberg","year":"2017","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.001_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/pharmaceutics14020433","article-title":"Skin Barrier Function in Infants: Update and Outlook","volume":"14","author":"Rahma","year":"2022","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.iac.2026.04.001_bib24","first-page":"CD009864","article-title":"Topical tacrolimus for atopic dermatitis","volume":"2015","author":"Cury Martins","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.iac.2026.04.001_bib25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jaad.2017.09.074","article-title":"A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis","volume":"78","author":"Yu","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.001_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/jid.2014.325","article-title":"Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study","volume":"135","author":"Silverberg","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.001_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamadermatol.2014.3432","article-title":"Association between eczema and stature in 9 US population-based studies","volume":"151","author":"Silverberg","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.001_bib28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jaad.2007.05.001","article-title":"The sensory profile of children with atopic dermatitis as determined by the sensory profile questionnaire","volume":"57","author":"Engel-Yeger","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.001_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.det.2005.05.009","article-title":"Massage therapy for skin conditions in young children","volume":"23","author":"Field","year":"2005","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.iac.2026.04.001_bib30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1525-1470.1998.tb01374.x","article-title":"Atopic dermatitis symptoms decreased in children following massage therapy","volume":"15","author":"Schachner","year":"1998","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.iac.2026.04.001_bib31","doi-asserted-by":"crossref","first-page":"1068043","DOI":"10.3389\/fpubh.2022.1068043","article-title":"The positive effect of mother-performed infant massage on infantile eczema and maternal mental state: A randomized controlled trial","volume":"10","author":"Lin","year":"2023","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.iac.2026.04.001_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0190-9622(91)70092-G","article-title":"Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis","volume":"24","author":"Vernon","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.001_bib33","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jaci.2023.08.030","article-title":"Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials","volume":"152","author":"Chu","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.001_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2500\/aap.2022.43.220057","article-title":"Capturing total steroid burden in patients with atopic dermatitis and asthma","volume":"43","author":"Fonacier","year":"2022","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.iac.2026.04.001_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2015.12.1323","article-title":"A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis","volume":"138","author":"Brunner","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.001_bib36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1684\/ejd.2023.4556","article-title":"Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas","volume":"33","author":"Luger","year":"2023","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.001_bib37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jaci.2022.08.026","article-title":"Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events","volume":"151","author":"Geba","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.001_bib38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jaad.2004.08.046","article-title":"Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination","volume":"52","author":"Papp","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.001_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jaad.2018.07.048","article-title":"Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis","volume":"80","author":"Blauvelt","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.001_bib40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40257-021-00607-6","article-title":"Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020","volume":"22","author":"Martinez-Cabriales","year":"2021","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.001_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/pde.15518","article-title":"A case series of live attenuated vaccine administration in dupilumab-treated children with atopic dermatitis","volume":"41","author":"Siegfried","year":"2024","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.iac.2026.04.001_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jdin.2021.01.001","article-title":"Therapeutic education in atopic dermatitis: A position paper from the International Eczema Council","volume":"3","author":"Eichenfield","year":"2021","journal-title":"JAAD Int"},{"issue":"5","key":"10.1016\/j.iac.2026.04.001_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.clindermatol.2018.05.003","article-title":"Developing an eczema action plan","volume":"36","author":"Levy","year":"2018","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.001_bib44","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.clindermatol.2018.05.006","article-title":"Experiences with the first eczema school in the United States","volume":"36","author":"Grossman","year":"2018","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.001_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40272-023-00611-9","article-title":"Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis","volume":"26","author":"Paller","year":"2024","journal-title":"Paediatr Drugs"},{"issue":"3","key":"10.1016\/j.iac.2026.04.001_bib46","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jaad.2016.04.066","article-title":"Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis","volume":"75","author":"Gonzalez","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.001_bib47","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1542\/peds.2008-2217","article-title":"Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity","volume":"123","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.iac.2026.04.001_bib48","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.36849\/JDD.6363","article-title":"aureus - Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis","volume":"20","author":"Moreau","year":"2021","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.iac.2026.04.001_bib49","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/jamapediatrics.2017.0556","article-title":"Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood","volume":"171","author":"Roduit","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.iac.2026.04.001_bib50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaci.2012.02.043","article-title":"Protection Against Allergy\u2013Study in Rural Environments study group. Development of atopic dermatitis according to age of onset and association with early-life exposures","volume":"130","author":"Roduit","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.001_bib51","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jaci.2013.12.1044","article-title":"PASTURE study group. Increased food diversity in the first year of life is inversely associated with allergic diseases","volume":"133","author":"Roduit","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.001_bib52","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-3038.2008.00808.x","article-title":"Association of Filaggrin loss-of-function-mutations with atopic dermatitis and asthma in the Early Treatment of the Atopic Child (ETAC) population","volume":"20","author":"M\u00fcller","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.001_bib53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-3038.1998.tb00356.x","article-title":"Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child","volume":"9","year":"1998","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.001_bib54","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1067\/mai.2001.120015","article-title":"ETAC Study Group. Early Treatment of the Atopic Child. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months\u2019 treatment and 18 months\u2019 posttreatment follow-up","volume":"108","author":"Warner","year":"2001","journal-title":"J Allergy Clin Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:44:07Z","timestamp":1783925047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856126000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0889856126000299"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2026.04.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Special Considerations in Atopic Dermatitis in Young Children","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2026.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}